全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Conservation/Mutation in the Splice Sites of Cytokine Receptor Genes of Mouse and Human

DOI: 10.1155/2013/818954

Full-Text   Cite this paper   Add to My Lib

Abstract:

Conservation/mutation in the intronic initial and terminal hexanucleotides was studied in 26 orthologous cytokine receptor genes of Mouse and Human. Introns began and ended with the canonical dinucleotides GT and AG, respectively. Identical configurations were found in 57% of the 5′ hexanucleotides and 28% of the 3′ hexanucleotides. The actual conservation percentages of the individual variable nucleotides at each position in the hexanucleotides were determined, and the theoretical rates of conservation of groups of three nucleotides were calculated under the hypothesis of a mutual evolutionary independence of the neighboring nucleotides (random association). Analysis of the actual conservation of groups of variable nucleotides showed that, at 5′, GTGAGx was significantly more expressed and GTAAGx was significantly less expressed, as compared to the random association. At 3′, TTTxAG and xTGCAG were overexpressed as compared to a random association. Study of Mouse and Human transcript variants involving the splice sites showed that most variants were not inherited from the common ancestor but emerged during the process of speciation. In some variants the silencing of a terminal hexanucleotide determined skipping of the downstream exon; in other variants the constitutive splicing hexanucleotide was replaced by another potential, in-frame, splicing hexanucleotide, leading to alterations of exon lengths. 1. Introduction In most protein-coding genes of eukaryotes the coding exons alternate with noncoding introns. The nuclear pre-mRNA is a transcript of the whole gene, including the introns. However, before it is exported to the cytoplasm, the introns are removed through a process called pre-mRNA splicing and the exons orderly joined to form the mature coding mRNA. Cutting at splicing sites is usually accomplished with a high degree of precision, as needed for the synthesis of the correct protein products in the process of translation. Precision splicing requires the existence of specific sequence arrangements at appropriate pre-mRNA sites (signals) and is affected by a massive ribonucleoprotein complex, the spliceosome, which has evolved to interact with these sequences. Most often the splicing signal is univocal and robust enough to allow one single splicing pattern only at each site. But when the splicing signals are less robust or possibly not univocal, “physiological” alternative splicing patterns may occur, with total or partial deletion of some exons or retention of in-frame introns resulting in alterations of the encoded protein product. In most of

References

[1]  S. Stamm, S. Ben-Ari, I. Rafalska et al., “Function of alternative splicing,” Gene, vol. 344, pp. 1–20, 2005.
[2]  A. J. Matlin, F. Clark, and C. W. J. Smith, “Understanding alternative splicing: towards a cellular code,” Nature Reviews Molecular Cell Biology, vol. 6, no. 5, pp. 386–398, 2005.
[3]  M. Hallegger, M. Llorian, and C. W. J. Smith, “Alternative splicing: global insights: minireview,” FEBS Journal, vol. 277, no. 4, pp. 856–866, 2010.
[4]  E. Conti and E. Izaurralde, “Nonsense-mediated mRNA decay: molecular insights and mechanistic variations across species,” Current Opinion in Cell Biology, vol. 17, no. 3, pp. 316–325, 2005.
[5]  F. Lejeune and L. E. Maquat, “Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells,” Current Opinion in Cell Biology, vol. 17, no. 3, pp. 309–315, 2005.
[6]  J. Weischenfeldt, J. Lykke-Andersen, and B. Porse, “Messenger RNA surveillance: neutralizing natural nonsense,” Current Biology, vol. 15, no. 14, pp. R559–R562, 2005.
[7]  E. V. Koonin, “The origin of introns and their role in eukaryogenesis: a compromise solution to the introns-early versus introns-late debate?” Biology Direct, vol. 1, no. 22, pp. 1–23, 2006.
[8]  J. P. Orengo and T. A. Cooper, “Alternative splicing in disease,” Advances in Experimental Medicine and Biology, vol. 623, pp. 212–223, 2007.
[9]  A. S. Solis, N. Shariat, and J. G. Patton, “Splicing fidelity, enhancers, and disease,” Frontiers in Bioscience, vol. 13, no. 5, pp. 1926–1942, 2008.
[10]  C. A. Pettigrew and M. A. Brown, “Pre-mRNA splicing aberrations and cancer,” Frontiers in Bioscience, vol. 13, no. 3, pp. 1090–1105, 2008.
[11]  M. A. Panaro, V. Mitolo, A. Cianciulli, P. Cavallo, C. I. Mitolo, and A. Acquafredda, “The HIV-1 Rev binding family of proteins: the dog proteins as a study model,” Endocrine, Metabolic and Immune Disorders, vol. 8, no. 1, pp. 30–46, 2008.
[12]  M. D. Adams, D. Z. Rudner, and D. C. Rio, “Biochemistry and regulation of pre-mRNA splicing,” Current Opinion in Cell Biology, vol. 8, no. 3, pp. 331–339, 1996.
[13]  A. R. Krainer, Eukaryotic mRNA Processing, Oxford University Press, New York, NY, USA, 1997.
[14]  C. B. Burge, T. Tuschl, and P. A. Sharp, Splicing of Precursors to mRNAs by the Spliceosome, Cold Spring Laboratory Harbor Press, Cold Spring Harbor, NY, USA, 1999.
[15]  B. J. Blencowe, “Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases,” Trends in Biochemical Sciences, vol. 25, no. 3, pp. 106–110, 2000.
[16]  X. H. Zhang and L. A. Chasin, “Computational definition of sequence motifs governing constitutive exon splicing,” Genes and Development, vol. 18, no. 11, pp. 1241–1250, 2004.
[17]  J. Hui, L. Hung, M. Heiner et al., “Intronic CA-repeat and CA-rich elements: a new class of regulators of mammalian alternative splicing,” EMBO Journal, vol. 24, no. 11, pp. 1988–1998, 2005.
[18]  J. L. Kabat, S. Barberan-Soler, P. McKenna, H. Clawson, T. Farrer, and A. M. Zahler, “Intronic alternative splicing regulators identified by comparative genomics in nematodes,” PLoS Computational Biology, vol. 2, no. 7, p. e86, 2006.
[19]  C. Dominguez and F. H.-T. Allain, “NMR structure of the three quasi RNA recognition motifs (qRRMs) of human hnRNP F and interaction studies with Bcl-x G-tract RNA: a novel mode of RNA recognition,” Nucleic Acids Research, vol. 34, no. 13, pp. 3634–3645, 2006.
[20]  L. A. Chasin, “Searching for splicing motifs,” Advances in Experimental Medicine and Biology, vol. 623, pp. 85–106, 2007.
[21]  L. H. Hung, M. Heiner, J. Hui, S. Schreiner, V. Benes, and A. Bindereif, “Diverse roles of hnRNP L in mammalian mRNA processing: a combined microarray and RNAi analysis,” RNA, vol. 14, no. 2, pp. 284–296, 2008.
[22]  M. A. Panaro, A. Cianciulli, R. Calvello et al., “An analysis of the human chemokine CXC receptor 4 gene,” Immunopharmacology and Immunotoxicology, vol. 31, no. 1, pp. 88–93, 2009.
[23]  J. Zhang, C. C. Kuo, and L. Chen, “GC content around splice sites affects splicing through pre-mRNA secondary structures,” BMC Genomics, vol. 12, no. 90, pp. 1–11, 2011.
[24]  T. W. Nilsen, “The spliceosome: the most complex macromolecular machine in the cell?” BioEssays, vol. 25, no. 12, pp. 1147–1149, 2003.
[25]  J. F. Abril, R. Castelo, and R. Guigó, “Comparison of splice sites in mammals and chicken,” Genome Research, vol. 15, no. 1, pp. 111–119, 2005.
[26]  N. Sheth, X. Roca, M. L. Hastings, T. Roeder, A. R. Krainer, and R. Sachidanandam, “Comprehensive splice-site analysis using comparative genomics,” Nucleic Acids Research, vol. 34, no. 14, pp. 3955–3967, 2006.
[27]  S. H. Schwartz, J. Silva, D. Burstein, T. Pupko, E. Eyras, and G. Ast, “Large-scale comparative analysis of splicing signals and their corresponding splicing factors in eukaryotes,” Genome Research, vol. 18, no. 1, pp. 88–103, 2008.
[28]  E. V. Kriventseva and M. S. Gelfand, “Statistical analysis of the exon-intron structure of higher and lower eukaryote genes,” Journal of Biomolecular Structure and Dynamics, vol. 17, no. 2, pp. 281–288, 1999.
[29]  M. Burset, I. A. Seledtsov, and V. V. Solovyev, “SpliceDB: database of canonical and non-canonical mammalian splice sites,” Nucleic Acids Research, vol. 29, no. 1, pp. 255–259, 2001.
[30]  M. Burset, I. A. Seledtsov, and V. V. Solovyev, “Analysis of canonical and non-canonical splice sites in mammalian genomes,” Nucleic Acids Research, vol. 28, no. 21, pp. 4364–4375, 2000.
[31]  V. Shepelev and A. Fedorov, “Advances in the exon-intron database (EID),” Briefings in Bioinformatics, vol. 7, no. 2, pp. 178–185, 2006.
[32]  M. Foote, J. P. Hunter, C. M. Janis, and J. J. Sepkoski Jr., “Evolutionary and preservational constraints on origins of biologic groups: divergence times of eutherian mammals,” Science, vol. 283, no. 5406, pp. 1310–1314, 1999.
[33]  M. S. Lee, “Molecular clock calibrations and metazoan divergence dates,” Journal of Molecular Evolution, vol. 49, no. 3, pp. 385–391, 1999.
[34]  K. M. Murphy, P. Travers, and M. Walport, Janeway's Immunobiology, Garland Science, Oxford, UK, 7th edition, 2007.
[35]  R. Coico and G. Sunshine, Immunology: A Short Course, Wiley-Blackwell, Hoboken, NJ, USA, 6th edition, 2008.
[36]  F. Corpet, “Multiple sequence alignment with hierarchical clustering,” Nucleic Acids Research, vol. 16, no. 22, pp. 10881–10890, 1988.
[37]  M. L. Samuels and J. A. Witmer, Statistics for the Life Sciences, Prentice Hall, Upper Saddle River, NJ, USA, 3rd edition, 2002.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413